AMPERA backs Silicon Valley’s Adelphi Technology to lock down exclusive rights to high-yield neutron-generation systems.
Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results